Jessica Wagner

2.5k total citations
24 papers, 751 citations indexed

About

Jessica Wagner is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jessica Wagner has authored 24 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Jessica Wagner's work include CAR-T cell therapy research (6 papers), Cell death mechanisms and regulation (6 papers) and Immunotherapy and Immune Responses (4 papers). Jessica Wagner is often cited by papers focused on CAR-T cell therapy research (6 papers), Cell death mechanisms and regulation (6 papers) and Immunotherapy and Immune Responses (4 papers). Jessica Wagner collaborates with scholars based in United States, France and Germany. Jessica Wagner's co-authors include Stephen Gottschalk, Elizabeth Wickman, Christopher DeRenzo, Wafik S. El‐Deiry, C. Leah B. Kline, Marie D. Ralff, David T. Dicker, Joshua E. Allen, Amriti R. Lulla and Lanlan Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Jessica Wagner

20 papers receiving 727 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jessica Wagner United States	12	408	344	213	104	74	24	751
Lingyu Li China	15	369 0.9×	273 0.8×	190 0.9×	39 0.4×	102 1.4×	35	785
Melanie Mediavilla-Varela United States	12	270 0.7×	379 1.1×	261 1.2×	51 0.5×	81 1.1×	28	860
Oleg Tikhomirov United States	13	294 0.7×	404 1.2×	365 1.7×	60 0.6×	65 0.9×	16	924
Rachele Alzani Italy	15	256 0.6×	251 0.7×	120 0.6×	31 0.3×	67 0.9×	26	589
Deblina Raychaudhuri India	11	461 1.1×	408 1.2×	604 2.8×	99 1.0×	173 2.3×	17	1.2k
Miwako Kakiuchi Japan	8	413 1.0×	443 1.3×	392 1.8×	73 0.7×	185 2.5×	14	1.1k
HuiYong Zhao United States	12	426 1.0×	584 1.7×	133 0.6×	38 0.4×	170 2.3×	18	1.1k
Yoshihiro Otani Japan	15	329 0.8×	373 1.1×	95 0.4×	54 0.5×	119 1.6×	65	853
Cheryl Li United States	11	189 0.5×	383 1.1×	168 0.8×	28 0.3×	79 1.1×	23	838
Natalia Di Ianni Italy	12	261 0.6×	200 0.6×	160 0.8×	89 0.9×	85 1.1×	15	533

Countries citing papers authored by Jessica Wagner

Since Specialization

Citations

This map shows the geographic impact of Jessica Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Wagner more than expected).

Fields of papers citing papers by Jessica Wagner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Wagner. The network helps show where Jessica Wagner may publish in the future.

Co-authorship network of co-authors of Jessica Wagner

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Wagner. A scholar is included among the top collaborators of Jessica Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Wagner. Jessica Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wickman, Elizabeth, Shannon Lange, Jessica Wagner, et al.. (2024). IL-18R supported CAR T cells targeting oncofetal tenascin C for the immunotherapy of pediatric sarcoma and brain tumors. Journal for ImmunoTherapy of Cancer. 12(11). e009743–e009743. 9 indexed citations

Shaw, Timothy I., Jessica Wagner, Liqing Tian, et al.. (2024). Discovery of immunotherapy targets for pediatric solid and brain tumors by exon-level expression. Nature Communications. 15(1). 3732–3732. 11 indexed citations

Adeshakin, Adeleye O., Peipei Zhou, Jean‐Yves Métais, et al.. (2023). Abstract 1778: B7-H3-CAR T-cell therapy in immune-competent osteosarcoma models: Regnase-1 KO overcomes limited CAR T-cell expansion. Cancer Research. 83(7_Supplement). 1778–1778. 1 indexed citations

Madine, Jillian, Hannah A. Davies, Raymond Q. Migrino, et al.. (2023). Medin amyloid may drive arterial aging and disease in the periphery and brain. Nature Aging. 3(9). 1039–1041. 3 indexed citations

Wagner, Jessica & Terrill Bravender. (2022). 50 Years Ago in T J P. The Journal of Pediatrics. 252. 75–75. 1 indexed citations

Talbot, Lindsay J., Phuong Nguyen, Jessica Wagner, et al.. (2021). A Novel Orthotopic Implantation Technique for Osteosarcoma Produces Spontaneous Metastases and Illustrates Dose-Dependent Efficacy of B7-H3-CAR T Cells. Frontiers in Immunology. 12. 691741–691741. 20 indexed citations

Wagner, Jessica, Elizabeth Wickman, Timothy I. Shaw, et al.. (2020). Antitumor Effects of CAR T Cells Redirected to the EDB Splice Variant of Fibronectin. Cancer Immunology Research. 9(3). 279–290. 36 indexed citations

Degenhardt, Karoline, Jessica Wagner, Angelos Skodras, et al.. (2020). Medin aggregation causes cerebrovascular dysfunction in aging wild-type mice. Proceedings of the National Academy of Sciences. 117(38). 23925–23931. 26 indexed citations

Wagner, Jessica, Elizabeth Wickman, Christopher DeRenzo, & Stephen Gottschalk. (2020). CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?. Molecular Therapy. 28(11). 2320–2339. 257 indexed citations

10.

Wagner, Jessica, C. Leah B. Kline, Lanlan Zhou, Vladimir Khazak, & Wafik S. El‐Deiry. (2018). Anti-tumor effects of ONC201 in combination with VEGF-inhibitors significantly impacts colorectal cancer growth and survival in vivo through complementary non-overlapping mechanisms. Journal of Experimental & Clinical Cancer Research. 37(1). 11–11. 29 indexed citations

11.

Wagner, Jessica, C. Leah B. Kline, Lanlan Zhou, et al.. (2018). Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment. Journal of Clinical Investigation. 128(6). 2325–2338. 55 indexed citations

12.

Ralff, Marie D., C. Leah B. Kline, Jessica Wagner, et al.. (2017). ONC201 Demonstrates Antitumor Effects in Both Triple-Negative and Non–Triple-Negative Breast Cancers through TRAIL-Dependent and TRAIL-Independent Mechanisms. Molecular Cancer Therapeutics. 16(7). 1290–1298. 38 indexed citations

13.

Kline, C. Leah B., Marie D. Ralff, Amriti R. Lulla, et al.. (2017). Role of Dopamine Receptors in the Anticancer Activity of ONC201. Neoplasia. 20(1). 80–91. 94 indexed citations

14.

Wagner, Jessica, C. Leah B. Kline, Lanlan Zhou, et al.. (2017). Abstract 124: Imipridone ONC201 promotes intra-tumoral accumulation of CD3+/NK+ cells that contribute to its anti-tumor efficacy. Cancer Research. 77(13_Supplement). 124–124.

15.

Wagner, Jessica, C. Leah B. Kline, Marie D. Ralff, et al.. (2017). Preclinical evaluation of the imipridone family, analogs of clinical stage anti-cancer small molecule ONC201, reveals potent anti-cancer effects of ONC212. Cell Cycle. 16(19). 1790–1799. 56 indexed citations

16.

Lev, Avital, Amriti R. Lulla, Jessica Wagner, et al.. (2017). Anti-pancreatic cancer activity of ONC212 involves the unfolded protein response (UPR) and is reduced by IGF1-R and GRP78/BIP. Oncotarget. 8(47). 81776–81793. 37 indexed citations

17.

Zhang, Shengliang, Jessica Wagner, Lanlan Zhou, & Wafik S. El‐Deiry. (2017). Abstract 1892: Small molecule NSC59984 prevents cancer cell migration and invasion. Cancer Research. 77(13_Supplement). 1892–1892. 1 indexed citations

18.

Lev, Avital, Amriti R. Lulla, Jessica Wagner, David T. Dicker, & Wafik S. El‐Deiry. (2017). Abstract 1067: Anti-cancer efficacy of imipridones in pancreatic cancer: single agent ONC212 or combination of ONC201 with IGF1-R inhibition. Cancer Research. 77(13_Supplement). 1067–1067. 1 indexed citations

19.

Wagner, Jessica, et al.. (2016). Abstract 3000: Intra-tumoral accumulation of NK1.1/CD3+ cells and anti-metastasis effects of dose-intensified ONC201 in tumor-bearing mice. Cancer Research. 76(14_Supplement). 3000–3000. 2 indexed citations

20.

Wagner, Jessica, et al.. (1963). ENCEPHALOPATHY AND FATTY DEGENERATION OF THE VISCERA. The Lancet. 282(7315). 1010–1010. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact